Results 51 to 60 of about 65,584 (272)

Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1

open access: yesClinics, 2012
The bone mineral density increments in patients with sporadic primary hyperparathyroidism after parathyroidectomy have been studied by several investigators, but few have investigated this topic in primary hyperparathyroidism associated with multiple ...
Flavia L. Coutinho   +4 more
doaj   +1 more source

Functional Advantage of Central Pancreatectomy Over Distal Pancreatectomy for Benign or Low‐Grade Malignant Tumors: A Comparative Analysis Based on 75‐g Oral Glucose Tolerance Test

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Central pancreatectomy (CP) better preserves postoperative pancreatic endocrine function than distal pancreatectomy for benign or low‐grade malignant tumors. The 75‐g oral glucose tolerance test demonstrated that CP maintained insulin secretion and glucose tolerance, highlighting its clinical advantage as a function‐preserving procedure.
Dongha Lee   +9 more
wiley   +1 more source

Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center

open access: yesClinics, 2012
Most cases of sporadic primary hyperparathyroidism present disturbances in a single parathyroid gland and the surgery of choice is adenomectomy. Conversely, hyperparathyroidism associated with multiple endocrine neoplasia type 1 (hyperparathyroidism ...
Fabio Luiz de Menezes Montenegro   +12 more
doaj   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay   +5 more
wiley   +1 more source

Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old

open access: yesF1000Research, 2017
Despite its identification in 1997, the functions of the MEN1 gene—the main gene underlying multiple endocrine neoplasia type 1 syndrome—are not yet fully understood.
A. Falchetti
semanticscholar   +1 more source

Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma

open access: yesJournal of the Endocrine Society, 2018
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant hereditary cancer syndrome caused by missense gain-of-function mutations in the RET proto-oncogene on chromosome 10.
F. Raue, K. Frank‐Raue
semanticscholar   +1 more source

Multiple endocrine neoplasia type 2A (Sipple syndrome)

open access: yesActa Medica Leopoliensia, 2017
Aim. To improve diagnosis and differential diagnosis of diseases with hypertension, including multiple endocrine meoplasia, their timely diagnosis and appropriate treatment of patients. Material and Methods.
O.V. Safonova   +2 more
doaj   +1 more source

Testicular histopathology and its association with germ cell numbers, serum concentrations of reproductive hormones, and semen quality

open access: yesAndrology, EarlyView.
Abstract Background It is well‐established that spermatogenesis, semen quality, and reproductive hormones are interlinked. It is, however, less well‐described how various specific testicular histopathologies are linked to reproductive hormones and semen quality.
Gülizar Saritas   +6 more
wiley   +1 more source

Breast cancer in multiple endocrine neoplasia type 1 (MEN1)

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2021
A 38-year-old female was identified as carrying a heterozygous pathogenic MEN1 variant (c.1304delG) through predictive genetic testing, following a diagnosis of familial hyperparathyroidism.
Seong Keat Cheah   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy